Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study

Autor: Savulescu C, Krizova P, Lepoutre A, Mereckiene J, Vestrheim DF, Ciruela Navas P, Ordobas M, Guevara M, McDonald E, Morfeldt E, Kozakova J, Varon E, Cotter S, Winje BA, Munoz-Almagro C, Garcia L, Castilla J, Smith A, Henriques-Normark B, Celentano LP, Hanquet G, SpIDnet group

Publikováno v: LANCET RESPIRATORY MEDICINE
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname

BACKGROUND: The Streptococcus pneumoniae Invasive Disease network (SpIDnet) actively monitors populations in nine sites in seven European countries for invasive pneumococcal disease. Five sites use 13-valent pneumococcal conjugate vaccine (PCV13) alo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1d887d86f9e3b65f14e88ee329d69d38
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=11077

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination.

Autor: Hanquet G; EpiConcept, Paris, France.; Antwerp University, Antwerp, Belgium., Krizova P; National Institute of Public Health, Prague, Czech Republic., Valentiner-Branth P; Statens Serum Institut, Copenhagen, Denmark., Ladhani SN; Public Health England, London, UK., Nuorti JP; National Institute for Health and Welfare, Helsinki, Finland.; University of Tampere, Tampere, Finland., Lepoutre A; Santé publique France, Saint-Maurice, France., Mereckiene J; Health Protection Surveillance Centre, Dublin, Ireland., Knol M; National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Winje BA; Norwegian Institute of Public Health, Oslo, Norway., Ciruela P; Public Health Agency of Catalunya, Barcelona, Spain.; CIBER Epidemiología y Salud Pública, Madrid, Spain., Ordobas M; General Directorate of Public Health, Madrid, Spain., Guevara M; CIBER Epidemiología y Salud Pública, Madrid, Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain., McDonald E; Health Protection Scotland, National Services Scotland, Glasgow, UK., Morfeldt E; Public Health Agency of Sweden, Solna, Sweden., Kozakova J; National Institute of Public Health, Prague, Czech Republic., Slotved HC; Statens Serum Institut, Copenhagen, Denmark., Fry NK; Public Health England, London, UK., Rinta-Kokko H; National Institute for Health and Welfare, Helsinki, Finland., Varon E; National Centre for Pneumococci, European Hospital George Pompidou, Paris, France., Corcoran M; Irish Pneumococcal Reference Laboratory, Temple Street Children's University Hospital, Dublin, Ireland., van der Ende A; Netherlands Reference Laboratory for Bacterial Meningitis, Academic Medical Centre, Amsterdam, The Netherlands., Vestrheim DF; Norwegian Institute of Public Health, Oslo, Norway., Munoz-Almagro C; CIBER Epidemiología y Salud Pública, Madrid, Spain.; Instituto de Recerca Pediátrica, Hospital Sant Joan de Deu, Universitat Internacional de Catalunya, Barcelona, Spain., Latasa P; General Directorate of Public Health, Madrid, Spain., Castilla J; CIBER Epidemiología y Salud Pública, Madrid, Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain., Smith A; Scottish Haemophilus, Legionella, Meningococcus and Pneumococcus Reference Laboratory, Glasgow, UK., Henriques-Normark B; Public Health Agency of Sweden, Solna, Sweden.; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden., Whittaker R; European Centre for Disease Prevention and Control, Stockholm, Sweden., Pastore Celentano L; European Centre for Disease Prevention and Control, Stockholm, Sweden., Savulescu C; EpiConcept, Paris, France.

Publikováno v: Thorax [Thorax] 2019 May; Vol. 74 (5), pp. 473-482. Date of Electronic Publication: 2018 Oct 24.

First secondary case of Ebola outside Africa: epidemiological characteristics and contact monitoring, Spain, September to November 2014.

Autor: Lópaz, M. A., Amela, C., Ordobas, M., Domínguez-Berjón, M. F., Álvarez, C., Martínez, M., Sierra, M. J., Simon, F., Jansá, J. M., Plachouras, D., Astray, J.

Publikováno v: Eurosurveillance (15607917); 1/8/2015, Vol. 20 Issue 1, p4-9, 6p, 1 Diagram, 2 Charts, 1 Graph